V. Les-modalités-de-l-'img and .. , 79 1. L'âge gestationnel moyen du début des explorations, p.79

. Qu, est-ce que l'interruption médicalisée de grossesse ? -ameli-santé [Internet]. [cité 13 juin 2016, Disponible sur

F. Muller, S. Dreux, I. Czerkiewicz, M. Bernard, J. Guibourdenche et al., D??pistage de la trisomie 21??par les marqueurs s??riques maternels??: justification des commentaires appliqu??s par les biologistes, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.43, issue.9, pp.671-680, 2014.
DOI : 10.1016/j.jgyn.2014.05.012

B. Delorme, M. Mas-caradec, D. Loisel, and . Irm-foetale, In: Le diagnostic prénatal en pratique, Internet], 2011.

M. Frates, A. Kumar, C. Benson, V. Ward, and C. Tempany, Fetal Anomalies: Comparison of MR Imaging and US for Diagnosis, Radiology, vol.232, issue.2, pp.398-404, 2004.
DOI : 10.1148/radiol.2322030504

C. Falip, P. Hornoy, M. Bellaïche, A. Merzoug, V. Adamsbaum et al., Imagerie par r??sonance magn??tique (IRM) f??tale c??r??brale??: indications, aspects normaux et pathologiques, Revue Neurologique, vol.165, issue.11, pp.875-88, 2009.
DOI : 10.1016/j.neurol.2009.01.036

P. Brugger and D. Prayer, Fetal abdominal magnetic resonance imaging, European Journal of Radiology, vol.57, issue.2, pp.278-93, 2006.
DOI : 10.1016/j.ejrad.2005.11.030

M. Hörmann, P. Brugger, C. Balassy, L. Witzani, and D. Prayer, Fetal MRI of the urinary system, European Journal of Radiology, vol.57, issue.2, pp.303-314, 2006.
DOI : 10.1016/j.ejrad.2005.11.028

D. Loisel and B. Delorme, Scanner f??tal, 2011.
DOI : 10.1016/B978-2-294-70962-3.00004-5

F. Biquard, C. Lefebvre-lacoeuille, and P. Descamps, Pr??l??vements f??taux, Internet], 2011.
DOI : 10.1016/B978-2-294-70962-3.00005-7

K. Eddleman, F. Malone, L. Sullivan, K. Dukes, R. Berkowitz et al., Pregnancy Loss Rates After Midtrimester Amniocentesis, Obstetrics & Gynecology, vol.108, issue.5, pp.1067-72, 2006.
DOI : 10.1097/01.AOG.0000240135.13594.07

A. Tabor, M. Madsen, E. Obel, J. Philip, J. Bang et al., Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. The Lancet, juin, vol.327, issue.8493, pp.1287-93, 1986.

J. Horovitz, J. Toutain, R. Saura, and F. Vandenbossche, choriocentèses et placentocentèses: aspects obstétricaux, cytologiques et histologiques. Mises à jours en gynécolgie et obstétrique, 2009423.

R. Saura, J. Horovitz, L. Taine, D. Roux, C. Hocke et al., A modified freehand ultrasonographically guided technique in transabdominal chorionic villus sampling, American Journal of Obstetrics and Gynecology, vol.167, issue.5, pp.1483-1487, 1992.
DOI : 10.1016/S0002-9378(11)91749-9

F. Vandenbossche, J. Horovitz, F. Guyon, C. Verret, and R. Saura, Pain experience during chorionic villus sampling and amniocentesis: A preliminary study, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.136, issue.2, pp.189-93, 2008.
DOI : 10.1016/j.ejogrb.2007.03.020

R. Saura, J. Toutain, and J. Horovitz, A freehand ultrasonographically guided technique in transabdominal chorionic villus sampling in more than 24 000 consecutive cases, Prenatal Diagnosis, vol.136, issue.2, pp.387-395, 2010.
DOI : 10.1002/pd.2476

J. Brun, R. Mangione, F. Gangbo, F. Guyon, L. Taine et al., Feasibility, accuracy and safety of chorionic villus sampling: a report of 10 741 cases, Prenatal Diagnosis, vol.14, issue.076, pp.295-301, 2003.
DOI : 10.1002/pd.578

Z. Alfirevic, F. Mujezinovic, and K. Sundberg, Amniocentesis and chorionic villus sampling for prenatal diagnosis, Disponible sur, 2003.
DOI : 10.1002/14651858.CD003252

F. Daffos, F. Forestier, C. Kaplan, and W. Cox, Prenatal diagnosis and management of bleeding disorders with fetal blood sampling, American Journal of Obstetrics and Gynecology, vol.158, issue.4, pp.939-985, 1988.
DOI : 10.1016/0002-9378(88)90098-1

L. Sentilhes, M. Mezzadri, C. Bélanger, B. Porcheron, P. Gillard et al., Interruption m??dicale de grossesse
DOI : 10.1016/B978-2-294-70962-3.00041-0

L. Mandelbrot and G. Girard, Aspects techniques des interruptions médicales de grossesse Mises à jour en gynécologie-obstétrique et techniques chirugicales, 2008041.

H. Wildschut, M. Both, S. Medema, E. Thomee, M. Wildhagen et al., Medical methods for mid-trimester termination of pregnancy, Disponible sur, 2011.
DOI : 10.1002/14651858.CD005216.pub2

O. Heikinheimo and R. Kekkonen, Dose-Response Relationships of RU 486, Annals of Medicine, vol.68, issue.1, pp.71-77, 1993.
DOI : 10.1056/NEJM198612183152501

J. Esteve, F. Gallego, M. Llorente, S. Bermúdez, E. Sala et al., Late second-trimester abortions induced with mifepristone, misoprostol and oxytocin: a report of 428 consecutive cases, Contraception, vol.78, issue.1, pp.52-60, 2008.
DOI : 10.1016/j.contraception.2008.02.016

D. Webster, G. Penney, and A. Templeton, A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol, BJOG: An International Journal of Obstetrics and Gynaecology, vol.56, issue.7, pp.706-715, 1996.
DOI : 10.1056/NEJM199504133321502

L. Nilas, M. Glavind-kristensen, T. Vejborg, and U. Knudsen, One or two day mifepristone???misoprostol interval for second trimester abortion, Acta Obstetricia et Gynecologica Scandinavica, vol.86, issue.9, pp.1117-1138, 2007.
DOI : 10.1080/00016340701505002

P. Chaudhuri, A. Mandal, C. Das, and A. Mazumdar, Dosing interval of 24 hours versus 48 hours between mifepristone and misoprostol administration for mid-trimester termination of pregnancy, International Journal of Gynecology & Obstetrics, vol.13, issue.(1), pp.134-142, 2014.
DOI : 10.1016/j.ijgo.2013.08.009

C. Mazouni, N. Vejux, J. Menard, A. Bruno, L. Boubli et al., Cervical preparation with laminaria tents improves induction-to-delivery interval in second- and third-trimester medical termination of pregnancy, Contraception, vol.80, issue.1, pp.101-105, 2009.
DOI : 10.1016/j.contraception.2009.01.013

L. Thornburg, D. Grace, A. Gray, J. Glantz, and E. Pressman, Placement of laminaria tents does not improve time to delivery in patients undergoing second trimester labor induction with misoprostol, The Journal of Maternal-Fetal & Neonatal Medicine, vol.111, issue.8, pp.928-959, 2010.
DOI : 10.3109/14767050903511552

S. Lee, H. Ralston, E. Drey, J. Partridge, and M. Rosen, Fetal Pain, JAMA, vol.294, issue.8, pp.947-54, 2005.
DOI : 10.1001/jama.294.8.947

M. Senat, C. Fischer, J. Bernard, and Y. Ville, The use of lidocaine for fetocide in late termination of pregnancy, BJOG: An International Journal of Obstetrics and Gynaecology, vol.81, issue.3, pp.296-300, 2003.
DOI : 10.1097/00000542-199903000-00014

J. Aubert, T. Bejan-angoulvant, and A. Jonville-bera, Pharmacologie du misoprostol (donn??es pharmacocin??tiques, tol??rance et effets t??ratog??nes), Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.43, issue.2, pp.114-136, 2014.
DOI : 10.1016/j.jgyn.2013.11.006

P. Ho, S. Ngai, K. Liu, G. Wong, and S. Lee, Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy, Obstetrics & Gynecology, vol.90, issue.5, pp.735-743, 1997.
DOI : 10.1016/S0029-7844(97)00419-5

J. Dickinson and S. Evans, A Comparison of Oral Misoprostol With Vaginal Misoprostol Administration in Second-Trimester Pregnancy Termination for Fetal Abnormality

V. Houfflin-debarge and P. Vaast, Interruption médicale de grossesse, 2008.

P. Ho, P. Blumenthal, K. Gemzell-danielsson, G. Ponce-de-león, R. Mittal et al., Misoprostol for the termination of pregnancy with a live fetus at 13 to 26??weeks, International Journal of Gynecology & Obstetrics, vol.111, issue.(0), pp.178-81, 2007.
DOI : 10.1016/j.ijgo.2007.09.007

D. Jannet, N. Aflak, A. Abankwa, B. Carbonne, L. Marpeau et al., Termination of 2nd and 3rd trimester pregnancies with mifepristone and misoprostol, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.70, issue.2, pp.159-63, 1996.
DOI : 10.1016/S0301-2115(95)02593-6

N. Kapp, L. Borgatta, P. Stubblefield, O. Vragovic, and N. Moreno, Mifepristone in Second-Trimester Medical Abortion, Obstetrics & Gynecology, vol.110, issue.6, pp.1304-1314, 2007.
DOI : 10.1097/01.AOG.0000289577.32274.a5

J. Dodd and C. Crowther, Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for women with a fetal anomaly or after intrauterine fetal death In: The Cochrane Collaboration, éditeur, Disponible sur, 2010.

A. Benachi and Y. Dumez, Interruption m??dicale de grossesse, Conduites pratiques en médecine foetale, 2010.
DOI : 10.1016/B978-2-294-70626-4.00020-5

P. Guillem, C. Racinet, A. Leynaud, A. Benbassa, and C. Cans, ??valuation de la morbidit?? maternelle apr??s interruption m??dicamenteuse de grossesse ?? partir de 12 semaines d???am??norrh??e, La Revue Sage-Femme, vol.3, issue.3, pp.227-238, 2003.
DOI : 10.1016/S1637-4088(04)72213-0

S. Goh and K. Thong, Induction of second trimester abortion (12???20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases, Contraception, vol.73, issue.5, pp.516-525, 2006.
DOI : 10.1016/j.contraception.2005.12.004

P. Ashok, A. Templeton, P. Wagaarachchi, and G. Flett, Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases, Contraception, vol.69, issue.1, pp.51-59, 2004.
DOI : 10.1016/j.contraception.2003.09.006

T. Lo, W. Lau, F. Lai, H. Lam, H. Tse et al., The effect of gestational age on the outcome of second-trimester termination of pregnancies for foetal abnormalities, Prenatal Diagnosis, vol.114, issue.6
DOI : 10.1002/pd.2012

M. Dommergues, A. Benachi, J. Benifla, R. Noettes, and Y. Dumez, The reasons for termination of pregnancy in the third trimester, BJOG: An International Journal of Obstetrics and Gynaecology, vol.104, issue.4, pp.297-303, 1999.
DOI : 10.1111/j.1471-0528.1999.tb08265.x

L. Ferris, M. Mcmain-klein, N. Colodny, G. Fellows, and J. Lamont, Factors associated with immediate abortion complications, CMAJ Can Med Assoc J. 1 juin, vol.154, issue.11, p.1677, 1996.

P. Darney and R. Sweet, Routine intraoperative ultrasonography for second trimester abortion reduces incidence of uterine perforation., Journal of Ultrasound in Medicine, vol.8, issue.2, pp.71-76, 1989.
DOI : 10.7863/jum.1989.8.2.71

A. Borrás, O. Gómez, M. Sanz, J. Martínez, and B. Puerto, Feticide Followed by Mifepristone-Misoprostol Regimen for Midtrimester Termination of Pregnancy in Two Cases of Complete Placenta Previa, Fetal Diagnosis and Therapy, vol.28, issue.2, pp.114-120, 2010.
DOI : 10.1159/000314038

A. Rossi, D. Addario, and V. , Umbilical cord occlusion for selective feticide in complicated monochorionic twins: a systematic review of literature, American Journal of Obstetrics and Gynecology, vol.200, issue.2, pp.123-132, 2009.
DOI : 10.1016/j.ajog.2008.08.039

E. Noblot, T. Raia-barjat, G. Noblot, and C. Chauleur, La césarienne vaginale doit-elle toujours se pratiquer ? Gynécologie Obstétrique Fertil, pp.402-405, 2015.

. Enfant-décédé-À-la-naissance, quelles sont les règles d'état civil ? | service-public

C. Du, relative à l'état civil des enfants décédés avant la déclaration de naissance, mort-nés ou nés sans vie et à la prise en charge des corps, 2009.

H. Chappé, P. Bétrémieux, V. Morel, M. Huillery, L. Bouar et al., L'interruption médicale de grossesse sans foeticide : une enquête nationale, J Gynécologie Obstétrique Biol Reprod

J. Jouannic, R. Favre, A. Benachi, and H. Laurichesse, R??ponse ?? l???article??: ????L???interruption m??dicale de grossesse sans f??ticide??: enqu??te nationale???? par Chapp?? et al. J Gynecol Obstet Biol Reprod 2015??Jul 20 [Epub ahead of print], Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.45, issue.1, pp.97-105, 2015.
DOI : 10.1016/j.jgyn.2015.11.006

M. Wyldes and A. Tonks, Termination of pregnancy for fetal anomaly: a population-based study 1995 to 2004, BJOG: An International Journal of Obstetrics & Gynaecology, vol.12, issue.5, pp.639-681, 1995.
DOI : 10.1111/j.1471-0528.2007.01279.x

H. Marret, F. Perrotin, P. Descamps, and A. De-magalhaes, Interruption médicale de grossesse aux 2 e et 3 e trimestre, Disponible sur, p.245, 2008.

C. Gascard-battisti, C. Dubois-lebbe, C. Chatelet-cheront, L. Ferrant, A. Sales et al., D??pistage ant??natal des cardiopathies f??tales: une ??tude r??trospective sur 20 ans, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.35, issue.5, 2008.
DOI : 10.1016/S0368-2315(06)76419-5

K. Nicolaides, C. Rodeck, P. Soothill, R. Warren, and C. Gosden, Why confine chorionic villus (placental) biopsy to the first trimester? The Lancet, mars, vol.327, issue.8480, pp.543-547, 1986.

P. Chieri and A. Aldini, Feasibility of placental biopsy in the second trimester for fetal diagnosis, American Journal of Obstetrics and Gynecology, vol.160, issue.3, pp.581-584, 1989.
DOI : 10.1016/S0002-9378(89)80032-8

R. Saura, M. Longy, O. Grison, J. Horovitz, and A. Vergnaud, Feasibility of placental biopsy in the secondtrimester for fetal diagnosis, American Journal of Obstetrics and Gynecology, vol.162, issue.5, pp.1362-1365, 1990.
DOI : 10.1016/0002-9378(90)90091-K

M. Dommergues, L. Mandelbrot, D. Mahieu-caputo, N. Boudjema, and I. Durand-zaleski, Termination of pregnancy following prenatal diagnosis in France: how severe are the foetal anomalies?, Prenatal Diagnosis, vol.114, issue.5, 2010.
DOI : 10.1002/pd.2510

URL : https://hal.archives-ouvertes.fr/hal-00928200

C. Lee, S. Lin, C. Lin, J. Shih, T. Lin et al., Clinical utility of array comparative genomic hybridisation for prenatal diagnosis: a cohort study of 3171 pregnancies, BJOG: An International Journal of Obstetrics & Gynaecology, vol.13, issue.5, pp.461-464, 2012.
DOI : 10.1111/j.1471-0528.2012.03279.x

R. Wapner, C. Martin, B. Levy, B. Ballif, C. Eng et al., Chromosomal Microarray versus Karyotyping for Prenatal Diagnosis, New England Journal of Medicine, vol.367, issue.23, pp.276-284, 2013.
DOI : 10.1056/NEJMoa1203382

F. Jacot, C. Poulin, A. Bilodeau, M. Morin, S. Moreau et al., A five-year experience with second-trimester induced abortions: No increase in complication rate as compared to the first trimester, American Journal of Obstetrics and Gynecology, vol.168, issue.2, pp.633-640, 1993.
DOI : 10.1016/0002-9378(93)90509-H

M. Dekhili, F. Vandenbossche, R. Saura, and J. Horovitz, Interruption de grossesse entre 12??et 18??SA??: comparaison des techniques m??dicale et chirurgicale, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.42, issue.7, p.707, 2013.
DOI : 10.1016/j.jgyn.2013.08.005

A. Nigam, V. Singh, and A. Prakash, Vaginal vs. oral misoprostol for mid-trimester abortion, International Journal of Gynecology & Obstetrics, vol.31, issue.3
DOI : 10.1016/j.ijgo.2005.11.010

P. Ramsey, K. Savage, T. Lincoln, and J. Owen, Vaginal Misoprostol Versus Concentrated Oxytocin and Vaginal PGE2 for Second-Trimester Labor Induction, Obstetrics & Gynecology, vol.104, issue.1, pp.138-183, 2004.
DOI : 10.1097/01.AOG.0000128947.31887.94

J. Dickinson and D. Doherty, Optimization of third-stage management after secondtrimester medical pregancy termination, Am J Obstet Gynecol. sept, vol.201, issue.3, pp.303-304, 2009.

I. Nygaard, A. Valbø, H. Heide, and M. Kresovic, Is oxytocin given during surgical termination of first trimester pregnancy useful? A randomized controlled trial, Acta Obstetricia et Gynecologica Scandinavica, vol.6, issue.2, pp.174-182, 2011.
DOI : 10.1111/j.1600-0412.2010.01025.x

C. Stoll, E. Garne, M. Clementi, . Euroscan-study, and . Group, Evaluation of prenatal diagnosis of associated congenital heart diseases by fetal ultrasonographic examination in Europe, Prenatal Diagnosis, vol.84, issue.4, pp.243-52, 2001.
DOI : 10.1002/pd.34

J. Protocole-anesthésique, Consultation anesthésie Bilan préopératoire J2 : Prémédication par Atarax100 per os Mise en place de la péridurale en l'absence de contre-indication

P. Protocole and . Sufentanyl, Bolus 5 µg Période réfractaire de 10 minutes puis PCEA bipuvacaïne (0,125%) ou naropeïne (0,15%) plus Sufentanyl